07 Jan 2001

Dexa-sine® | (Dexa-sine® Augentropfen) - Deutschland

Updated: 07 Jan 2001

Dexa-sine® | -SE

Behandl. v. nichtinfektiösen entzündl. Erkrank. der Bindehaut, der Hornhaut u. d. vorderen Augenabschnittes, auch Allergien, Reizungen, Verbrennungen u. Verätzungen.

Dexa-sine® | Description, Presentation and Dosage

Dexa-sine® | Description

Dexa-sine® | Drug Class Description

Einzelstoffe

Dexa-sine® | Drug Description

1 ml enth.: Dexamethasondihydrogenphosphat-Dinatrium 1 mg.

Dexa-sine® | Generic Name

Dexa-sine® Augentropfen

Dexa-sine® | Presentation

Dexa-sine® | Presentation

Dexa-sine®/-SE

Dexa-sine® | Manufacturer

Alcon

Related Learning Zones

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Oral Anticoagulation Reversal Knowledge Centre

Oral Anticoagulation Reversal Knowledge Centre

The Oral Anticoagualtion Reversal Knowledge Centre is intended to provide healthcare professionals with accurate information on the approaches to oral anticoagulation reversal for patients who experience or are at risk of significant bleeding, or require surgery. Content is arranged within illustrated and referenced sections including management of bleeding risk, oral anticoagulants, symposium highlights, key publication summaries and more.

This resource is developed by EPG Health Media (Europe) Ltd for epgonline.org in collaboration with CSL Behring, with content provided by CSL Behring.

This resource is not intended for healthcare professionals outside Europe.

Dexa-sine® | Dosage

Dexa-sine® | Adult Dosage

Benzalkoniumchlorid, Dinatriumedetat 2H2O, Povidon, Natriumchlorid, Natriummonohydrogenphosphat 12H2O, gereinigtes Wasser.

Dexa-sine® | Child Dosage


Dexa-sine® SE Augentropfen in Einmaldosen
Zus.: 1 ml enth.: Dexamethasondihydrogenphosphat-Dinatrium 1,315 mg (entspr. 1 mg Dexamethason).
Weit. Bestandteile: Dinatriumedetat 2H2O, Natriumchlorid, Natriumdihydrogenphosphat 2H2O, Natriummonohydrogenphosphat H2O-frei, gereinigtes Wasser.

Dexa-sine® | Precautions, Reactions and Contraindications

Dexa-sine® | Special Precautions

Dexa-sine® | Special Precautions

G 13

Dexa-sine® | Adverse Reactions

Dexa-sine® | Adverse Reactions

G 13 a

Related Drugs - Eye Health and Disorders

Back to top